Amgen Inc. (NASDAQ:AMGN)

Monday, July 27, 2009 | Web News
Revenues for 2009 are trending towards the upper end of the current guidance range of $14.4 to $14.8 billion. Amgen has increased its previously...
Monday, January 26, 2009 | Web News
Guidance Report: > * EPS Figures exclude one time charges and gains (Non-GAAP). Source: PR Newswire (...
See All Research...
Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives.

Web site:

Last updated March 5, 2008

Market Data powered by QuoteMedia. Terms of Use